🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

🔎 A fully loaded #PPLC2025 session on all things #myelofibrosis & #mpnsm Mahalo for the insight ! & clinical nuggets of Drs. Naveen Pemmaraju, MD, Ruben A. Mesa, MD, Laura C. Michaelis, Toyosi Odenike - for walking us through 🔄 evolving strategies in disease modification—from combos ➕ to immune

404k times used (and counting 🤯) What better way to kick off the #MDSSM session at #2025PPLC than highlighting the profound impact the IPSS-M has had in guiding personalized treatment decisions for better outcomes in patients with #MDS by Dr. Elli Papaemmanuil, PhD

⁦Dr. Uma Borate: Associate Professor⁩ finishing her outstanding talk on CHIP mutations at the Pan Pacific Conference in Maui. ⁦The James⁩ ⁦Ohio State Hematology⁩

#2025PPLC - my talk about Ohio State Hematology The James early identification and interception strategies for myeloid malignancies. First time my children heard me speak & I got an A grade from what is typically a tough crowd !

CONGRATULATIONS Abdullah M. Khan! #BuckeyePride

Last day ☹️ PPLC Leukemia, but only a year until PPLC 2026 Lymphoma!

Studying myelodysplastic syndromes (MDS)? Here's an overview of current humanized and genetically engineered mouse models suitable for studying MDS. ✅ Check it out! go.nature.com/3IBFYeb

Happy & honored to join giants in Leukemia Care at the #PPLC25 meeting at #Maui 🔹Updates on the management of chronic & acute #leukemia 🔹Exciting strategies under development 🎯 Same goal 🟰 improve patient outcomes 🙏 Nitin Jain Jorge Cortes MD #leusm #CML

External factors impact outcomes in blood cancer patients as well as. See 👇🏾

Time to mark our calendars moving for our 3rd "Probing Human Disease using Single-Cell Technologies" Fusion Conferences taking place March 1-4, 2026 in beautiful Playa Mujeres, Mexico!! Our first 15 speakers are already on board and Early Bird and Talk submissions on Sept 3rd! Dont

See 👇🏾 for the summary of this fantastic panel discussing all things MDS classification & risk stratification Ohio State Hematology The James

Sex at birth may not be purely random, according to a new Science Advances study. Instead, each family’s likelihood of having only male or only female children is a “weighted coin toss” influenced by maternal age and genetics. scim.ag/3GwnP0S

🎉 The Pelotonia 2025 Opening Ceremony is almost here! Join us as we honor the riders, researchers, and supporters fueling the fight to #EndCancer. 📅 Friday, August 1 📍 McFerson Commons 🎤 Inspiring speakers, music, and more! 🔗 pelotonia.org/opening-ceremo… #OneGoal #Pelotonia

I am from India. My ANC as far back I remember hovers between 1200-1600. I am from a part of Kolkata where Plasmodium vivax was common when I grew up. I never had malaria. What blood type am I?

emjreviews.com/hematology/jou… Spectrum, prevalence, and clinical correlates of PPM1D mutations in patients with clonal hematopoiesis and clonal cytopenias: highlights from #EHA2025 #EHA25

👇🏾 Incredibly harmful for our cancer patients who rely on novel clinical trials with new drugs that can be potentially effective against their disease.

Fascinating 🇩🇪 insights into relation between carfilzomib, T cells, CHIP, neutrophils, & DILI (pneumonitis) in sad case of myeloma. To see case report in Haematologica speaks to the complexity of their correlative analyses. So much more we have to learn about CHIP in #MMsm!

True pleasure to co-chair an outstanding Medical Crossfire in hematologic malignancies meeting in New York City with my co-chairs Dr Saad Usmani Saad Z. Usmani MD MBA FACP 🇺🇸🇵🇰 & Dr Barbara Pro Barbara Pro with top faculty such as Rami Komrokji Rami komrokji Yazan Madanat Yazan Madanat, MD Yasmin Abaza

🔥In our New series: “Challenging Cases” from the community, we touch on R/R FLT3+ AML treatment options with Dr. Uma Borate: Associate Professor and Naval Daver, M.D. Full discussion: ⭐️ oncbrothers.com/cases-flt3-2025 ⭐️ Also on the “Oncology Brothers” podcast #HemeTwitter #OncTwitter

Very cool!! Congrats to the authors ⁦Blood Journals Portfolio⁩ #hemepath Impaired cytotoxic function and exhausted phenotype of natural killer cells in VEXAS syndrome | Blood | American Society of Hematology ashpublications.org/blood/article/…